mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
8e-08 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-07 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-07 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
4e-06 |